UAQP stands for Universal Access to Quality Medicines Program. It is a term that refers to a global initiative aimed at ensuring that all individuals have equitable access to high-quality medicines. The UAQP program recognizes the fundamental importance of promoting and providing universal access to medicines for the well-being of individuals and communities worldwide.
The primary objective of the UAQP is to address the challenges and barriers that hinder access to quality medicines, particularly in low- and middle-income countries. It emphasizes the need to improve healthcare systems and infrastructures to ensure the availability, affordability, and appropriate use of essential medicines. The program seeks to promote the rational use of medicines, enhance pharmaceutical supply chains, and strengthen regulatory frameworks to ensure the quality and safety of medicines.
UAQP encourages collaboration among governments, international organizations, civil society, and the private sector to overcome socio-economic and geographical disparities in accessing medications. It emphasizes the importance of evidence-based decision-making, research, and innovation to develop and deliver cost-effective, quality-assured medicines. The program also supports capacity-building and technical assistance to empower healthcare practitioners and policymakers in promoting universal access to quality medicines.
Through the UAQP, it is envisioned that individuals, regardless of their economic status or geographic location, will have equal access to essential medicines, leading to improved health outcomes, reduced morbidity and mortality rates, and enhanced healthcare systems.
